Literature DB >> 17609438

Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.

Johanna L Barclay1, Stephen T Anderson, Michael J Waters, Jon D Curlewis.   

Abstract

Suppressor of cytokine signaling 3 (SOCS3) is expressed by lymphoid cells and can modulate the sensitivity of these cells to cytokine stimulation through inhibition of Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathways. This study employed a mouse pro-B cell line expressing the human GH receptor (BaF/3-GHR), to elucidate the signal transduction pathways used by GH to elicit SOCS3 expression. GH treatment of these cells caused a rapid, dose-dependent increase in SOCS3 mRNA expression, which was independent of de novo protein synthesis. As expected, GH treatment increased JAK-dependent STAT5 tyrosine phosphorylation, which bound to the proximal STAT response element (pSRE) on the SOCS3 promoter. This process appeared to involve STAT5b, rather than STAT5a. In addition, GH activation of the SOCS3 promoter required a nearby activator protein (AP) 1/cAMP response element (CRE), which bound cAMP response element binding protein, c-Fos, and c-Jun. Moreover, inhibitors of p38 MAPK and c-Jun N-terminal kinase prevented GH-stimulation of SOCS3 mRNA expression in these cells, suggesting a role for these kinases in SOCS3 transcription. Importantly, GH stimulation increased binding of FOXO3a to the SOCS3 promoter at a site overlapping the AP1/CRE response element, and overexpression of FOXO3a in these cells augmented SOCS3 promoter activation. In addition, we show a direct interaction between FOXO3a and STAT5 in these cells, which may provide a link between STAT5 and the AP1 transcription factors on the SOCS3 promoter. We conclude that regulation of SOCS3 expression by GH in a pro-B cell involves not only the pSRE, but also a transcriptionally active complex involving cAMP response element binding protein/c-Fos/c-Jun and FOXO3a. This study has implications for cytokine regulation of SOCS gene expression in lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609438     DOI: 10.1210/me.2006-0498

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

Review 2.  Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways.

Authors:  Dennis D Taub; William J Murphy; Dan L Longo
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

3.  Bromodomain and Extraterminal Inhibition by JQ1 Produces Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes.

Authors:  Paula Mota de Sá; Allison J Richard; Jacqueline M Stephens
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

4.  Inhibition of endogenous MTF-1 signaling in zebrafish embryos identifies novel roles for MTF-1 in development.

Authors:  Britton O'Shields; Andrew G McArthur; Andrew Holowiecki; Martin Kamper; Jeffrey Tapley; Matthew J Jenny
Journal:  Biochim Biophys Acta       Date:  2014-04-18

5.  Loss of DBC1 (CCAR2) affects TNFα-induced lipolysis and Glut4 gene expression in murine adipocytes.

Authors:  Ashley A Able; Allison J Richard; Jacqueline M Stephens
Journal:  J Mol Endocrinol       Date:  2018-10-15       Impact factor: 5.098

6.  SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth.

Authors:  Ye Sun; Meihua Ju; Zhiqiang Lin; Thomas W Fredrick; Lucy P Evans; Katherine T Tian; Nicholas J Saba; Peyton C Morss; William T Pu; Jing Chen; Andreas Stahl; Jean-Sébastien Joyal; Lois E H Smith
Journal:  Sci Signal       Date:  2015-09-22       Impact factor: 8.192

7.  Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.

Authors:  Y D Kim; Y H Kim; Y M Cho; D K Kim; S W Ahn; J M Lee; D Chanda; M Shong; C H Lee; H S Choi
Journal:  Diabetologia       Date:  2012-02-21       Impact factor: 10.122

8.  Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3.

Authors:  KyeongJin Kim; Kook Hwan Kim; JaeHun Cheong
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

Review 9.  Foxo3a: an integrator of immune dysfunction during HIV infection.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

10.  Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.

Authors:  Brandi J Baker; Hongwei Qin; Etty N Benveniste
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.